| 1 | [SID49675326] | Active | IC50 | 5.526 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | IC50 | 5.526 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651968 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 2 | [SID49675326] | Active | IC50 | 5.526 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | IC50 | 5.526 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651968 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 3 | [SID49675326] | Active | IC50 | 5.526 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | IC50 | 5.526 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651968 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 4 | [SID49675326] | Active | IC50 | 9.501 | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | IC50 | 9.501 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651970 | | BioAssay type | confirmatory | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 5 | [SID49675326] | Active | IC50 | 9.501 | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | IC50 | 9.501 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651970 | | BioAssay type | confirmatory | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 6 | [SID49675326] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID49675326] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 8 | [SID49675326] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 9 | [SID49675326] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 10 | [SID49675326] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 11 | [SID49675326] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 12 | [SID49675326] | Active | | | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity [AID488896, Type: screening] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Active | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488896 | | BioAssay type | screening | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 13 | [SID49675326] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 14 | [SID49675326] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 15 | [SID49675326] | Inactive | IC50 | 35.868 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID651973, Type: confirmatory] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | IC50 | 35.868 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 651973 | | BioAssay type | confirmatory | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 16 | [SID49675326] | Inactive | IC50 | 35.868 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts [AID651969, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | IC50 | 35.868 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts | | AID | 651969 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID49675326] | Inactive | Potency | 39.8107 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | Potency | 39.8107 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 18 | [SID49675326] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 19 | [SID49675326] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 20 | [SID49675326] | Inactive | | | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity [AID493131, Type: screening] | protein fosB [Mus musculus] [gi:6679827] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity | | AID | 493131 | | BioAssay type | screening | | Target | protein fosB [Mus musculus] [gi:6679827] | | PubMed | | | Data Table |  |
|
| 21 | [SID49675326] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 22 | [SID49675326] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 23 | [SID49675326] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 24 | [SID49675326] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 25 | [SID49675326] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 26 | [SID49675326] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 27 | [SID49675326] | Inactive | Potency | | qHTS of IL-2 Activators [AID652025, Type: confirmatory] | Il2 gene product [Mus musculus] [gi:7110653] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of IL-2 Activators | | AID | 652025 | | BioAssay type | confirmatory | | Target | Il2 gene product [Mus musculus] [gi:7110653] | | PubMed | | | Data Table |  |
|
| 28 | [SID49675326] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 29 | [SID49675326] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 30 | [SID49675326] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 31 | [SID49675326] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 [AID1672, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 | | AID | 1672 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|
| 32 | [SID49675326] | Inactive | IC50 | | Fluorescence for the identification of compounds that decrease p/CIP protein stability [AID1984, Type: confirmatory] | nuclear receptor coactivator 3 [Mus musculus] [gi:118026946] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Fluorescence for the identification of compounds that decrease p/CIP protein stability | | AID | 1984 | | BioAssay type | confirmatory | | Target | nuclear receptor coactivator 3 [Mus musculus] [gi:118026946] | | PubMed | | | Data Table |  |
|
| 33 | [SID49675326] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex [AID504707, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex | | AID | 504707 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] | | PubMed | | | Data Table |  |
|
| 34 | [SID49675326] | Inactive | Potency | | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 35 | [SID49675326] | Inactive | Potency | | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 36 | [SID49675326] | Inactive | Potency | | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 37 | [SID49675326] | Inactive | Potency | | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 38 | [SID49675326] | Inactive | | | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity [AID602393, Type: screening] | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602393 | | BioAssay type | screening | | Target | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] | | PubMed | | | Data Table |  |
|
| 39 | [SID49675326] | Inactive | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|
| 40 | [SID49675326] | Inactive | | | Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity [AID540336, Type: screening] | hypothetical protein CaO19.7491 [Candida albicans SC5314] [gi:68474550] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 540336 | | BioAssay type | screening | | Target | hypothetical protein CaO19.7491 [Candida albicans SC5314] [gi:68474550] | | PubMed | | | Data Table |  |
|
| 41 | [SID49675326] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). [AID1962, Type: screening] | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). | | AID | 1962 | | BioAssay type | screening | | Target | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] | | PubMed | | | Data Table |  |
|
| 42 | [SID49675326] | Inactive | Potency | | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase [AID485367, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase | | AID | 485367 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 43 | [SID49675326] | Inactive | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID624268, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 624268 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 44 | [SID49675326] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1). [AID1950, Type: screening] | EBNA-1 protein [Human herpesvirus 4] [gi:23893623] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1). | | AID | 1950 | | BioAssay type | screening | | Target | EBNA-1 protein [Human herpesvirus 4] [gi:23893623] | | PubMed | | | Data Table |  |
|
| 45 | [SID49675326] | Inactive | | | Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA. [AID2234, Type: screening] | BZLF1 [Human herpesvirus 4] [gi:82503229] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA. | | AID | 2234 | | BioAssay type | screening | | Target | BZLF1 [Human herpesvirus 4] [gi:82503229] | | PubMed | | | Data Table |  |
|
| 46 | [SID49675326] | Inactive | | | Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity [AID504558, Type: screening] | LMP1 [Human herpesvirus 4] [gi:23893668] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504558 | | BioAssay type | screening | | Target | LMP1 [Human herpesvirus 4] [gi:23893668] | | PubMed | | | Data Table |  |
|
| 47 | [SID49675326] | Inactive | Potency | | qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase [AID602233, Type: confirmatory] | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase | | AID | 602233 | | BioAssay type | confirmatory | | Target | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | | PubMed | | | Data Table |  |
|
| 48 | [SID49675326] | Inactive | | | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity [AID652162, Type: screening] | Toxin B [Clostridium difficile 630] [gi:126698238] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652162 | | BioAssay type | screening | | Target | Toxin B [Clostridium difficile 630] [gi:126698238] | | PubMed | | | Data Table |  |
|
| 49 | [SID49675326] | Inactive | | | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction [AID2629, Type: screening] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 2629 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 50 | [SID49675326] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set [AID588499, Type: Literature] | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49675326 | | CID | 16324405 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | | AID | 588499 | | BioAssay type | Literature | | Target | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] | | PubMed | 16604538 | | Data Table |  |
|